A pyrazolo[3,4-b]pyridine-5-carbonitrile derivative was diazotized to give the corresponding diazonium salt, which was used as a good synthon to synthesize pyrido[2′,3′:3,4]pyrazolo[5,1-c]triazines via its coupling with several active hydrogen-containing reagents, e.g., 2,4-pentandione, ethyl 3-oxo-butanoate, diethylmalonate, malononitrile, 2-cyanoethanethioamide, and ethyl cyanoacetate. Also, it reacted with phenylisothiocyanate to afford the corresponding pyrazolo[3,4-b]pyridin-3-ylphenylthiourea derivative, which, in turn, was used for further chemical transformations. The data of IR, 1 H NMR, mass spectra, and chemical analyses elucidated the structures of all newly synthesized heterocyclic compounds. Cytotoxicity, anti–HSV1 and anti–HAV, and MBB activities were evaluated for all newly synthesized heterocyclic compounds.
No takes yet. Share an insight, caveat, or question.
Attaby et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: